| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Peripheral Nervous System Diseases | 24 | 2021 | 710 | 2.420 |
Why?
|
| Polyradiculoneuropathy | 31 | 2007 | 65 | 2.310 |
Why?
|
| Amnesia, Transient Global | 3 | 2023 | 20 | 2.080 |
Why?
|
| Intracranial Hypertension | 4 | 2015 | 193 | 1.510 |
Why?
|
| Neurosyphilis | 3 | 2019 | 27 | 1.360 |
Why?
|
| Neurology | 7 | 2016 | 780 | 1.200 |
Why?
|
| Neuroleptic Malignant Syndrome | 1 | 2024 | 74 | 0.920 |
Why?
|
| JC Virus | 4 | 2012 | 87 | 0.810 |
Why?
|
| Sensation Disorders | 4 | 2015 | 160 | 0.790 |
Why?
|
| Intracranial Pressure | 16 | 2012 | 324 | 0.760 |
Why?
|
| Leukoencephalopathy, Progressive Multifocal | 4 | 2012 | 133 | 0.760 |
Why?
|
| Encephalocele | 6 | 2008 | 135 | 0.750 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 3 | 2012 | 556 | 0.730 |
Why?
|
| Intracranial Thrombosis | 1 | 2021 | 108 | 0.710 |
Why?
|
| Polyneuropathies | 7 | 2009 | 137 | 0.700 |
Why?
|
| Sinus Thrombosis, Intracranial | 1 | 2021 | 110 | 0.700 |
Why?
|
| Brain Injuries | 8 | 2015 | 2053 | 0.690 |
Why?
|
| Guillain-Barre Syndrome | 4 | 2009 | 127 | 0.690 |
Why?
|
| Hematoma, Subdural, Chronic | 1 | 2020 | 95 | 0.660 |
Why?
|
| Spinal Cord Compression | 2 | 2017 | 235 | 0.640 |
Why?
|
| Dura Mater | 1 | 2020 | 290 | 0.630 |
Why?
|
| Demyelinating Diseases | 11 | 2010 | 351 | 0.600 |
Why?
|
| Diabetic Neuropathies | 6 | 2009 | 405 | 0.570 |
Why?
|
| Soccer | 1 | 2019 | 142 | 0.560 |
Why?
|
| Neurologic Examination | 8 | 2012 | 916 | 0.550 |
Why?
|
| Prednisone | 3 | 2016 | 1563 | 0.540 |
Why?
|
| Penicillins | 1 | 2019 | 402 | 0.530 |
Why?
|
| Diuretics, Osmotic | 2 | 2014 | 33 | 0.530 |
Why?
|
| Epidural Abscess | 1 | 2017 | 94 | 0.520 |
Why?
|
| Immunosuppressive Agents | 4 | 2012 | 4174 | 0.510 |
Why?
|
| Thymectomy | 1 | 2016 | 195 | 0.510 |
Why?
|
| Paraproteinemias | 5 | 2004 | 248 | 0.510 |
Why?
|
| Saline Solution, Hypertonic | 2 | 2014 | 114 | 0.500 |
Why?
|
| Mannitol | 2 | 2014 | 180 | 0.500 |
Why?
|
| Foramen Ovale, Patent | 1 | 2017 | 208 | 0.480 |
Why?
|
| Plasma Exchange | 6 | 2006 | 158 | 0.480 |
Why?
|
| Sciatica | 1 | 2015 | 97 | 0.470 |
Why?
|
| Neural Conduction | 15 | 2009 | 441 | 0.470 |
Why?
|
| Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | 3 | 2007 | 34 | 0.460 |
Why?
|
| Myasthenia Gravis | 2 | 2016 | 214 | 0.450 |
Why?
|
| Cerebellar Diseases | 4 | 2003 | 220 | 0.450 |
Why?
|
| Nervous System Diseases | 8 | 2010 | 1666 | 0.430 |
Why?
|
| Immunoglobulins, Intravenous | 8 | 2007 | 664 | 0.430 |
Why?
|
| Dexamethasone | 2 | 2020 | 1948 | 0.430 |
Why?
|
| Migraine Disorders | 3 | 2022 | 1701 | 0.430 |
Why?
|
| Football | 1 | 2019 | 503 | 0.430 |
Why?
|
| Embolism, Fat | 1 | 2012 | 46 | 0.410 |
Why?
|
| Connective Tissue Diseases | 1 | 2015 | 285 | 0.410 |
Why?
|
| Thyroid Diseases | 1 | 2015 | 386 | 0.400 |
Why?
|
| Fumarates | 1 | 2012 | 131 | 0.390 |
Why?
|
| Humans | 198 | 2024 | 761504 | 0.390 |
Why?
|
| Sciatic Nerve | 2 | 2015 | 617 | 0.390 |
Why?
|
| Peripheral Nerves | 9 | 2009 | 479 | 0.390 |
Why?
|
| Somatosensory Cortex | 1 | 2015 | 512 | 0.390 |
Why?
|
| Paralysis | 4 | 2010 | 250 | 0.380 |
Why?
|
| Diffuse Axonal Injury | 1 | 2011 | 49 | 0.370 |
Why?
|
| Antipsychotic Agents | 1 | 2024 | 3067 | 0.370 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2020 | 1809 | 0.370 |
Why?
|
| Intracranial Embolism | 1 | 2012 | 189 | 0.370 |
Why?
|
| Sjogren's Syndrome | 3 | 2020 | 237 | 0.370 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2014 | 485 | 0.360 |
Why?
|
| POEMS Syndrome | 1 | 2010 | 12 | 0.350 |
Why?
|
| Spinal Neoplasms | 1 | 2017 | 716 | 0.350 |
Why?
|
| Hypothermia, Induced | 1 | 2015 | 753 | 0.350 |
Why?
|
| Spinal Diseases | 1 | 2015 | 564 | 0.340 |
Why?
|
| Craniotomy | 1 | 2014 | 741 | 0.330 |
Why?
|
| Plasmacytoma | 1 | 2010 | 171 | 0.330 |
Why?
|
| Spinal Cord Injuries | 1 | 2017 | 925 | 0.330 |
Why?
|
| Nerve Fibers | 2 | 2007 | 708 | 0.320 |
Why?
|
| Medical Records | 1 | 2014 | 1408 | 0.320 |
Why?
|
| Wallerian Degeneration | 1 | 2009 | 68 | 0.320 |
Why?
|
| Educational Measurement | 1 | 2016 | 1254 | 0.320 |
Why?
|
| Mental Processes | 1 | 2010 | 244 | 0.310 |
Why?
|
| Rheumatic Diseases | 1 | 2015 | 649 | 0.310 |
Why?
|
| Music | 1 | 2011 | 245 | 0.310 |
Why?
|
| Sacrum | 1 | 2010 | 276 | 0.300 |
Why?
|
| Eclampsia | 1 | 2008 | 56 | 0.300 |
Why?
|
| Monitoring, Physiologic | 6 | 2012 | 1779 | 0.300 |
Why?
|
| Meningocele | 1 | 2008 | 47 | 0.290 |
Why?
|
| Gastrointestinal Diseases | 2 | 2015 | 1200 | 0.290 |
Why?
|
| Paresthesia | 4 | 1995 | 162 | 0.290 |
Why?
|
| Blast Injuries | 1 | 2011 | 322 | 0.290 |
Why?
|
| Pain Measurement | 4 | 2013 | 3550 | 0.290 |
Why?
|
| Persistent Vegetative State | 1 | 2010 | 273 | 0.280 |
Why?
|
| Brain Stem | 10 | 1993 | 858 | 0.280 |
Why?
|
| Publishing | 1 | 2014 | 833 | 0.280 |
Why?
|
| Glucocorticoids | 1 | 2016 | 2161 | 0.280 |
Why?
|
| Hot Temperature | 1 | 2013 | 1440 | 0.270 |
Why?
|
| Brain Edema | 7 | 2003 | 604 | 0.260 |
Why?
|
| Gene Transfer Techniques | 3 | 2009 | 1206 | 0.260 |
Why?
|
| Brain Concussion | 2 | 2007 | 1404 | 0.260 |
Why?
|
| Clinical Competence | 2 | 2016 | 4792 | 0.260 |
Why?
|
| Monoclonal Gammopathy of Undetermined Significance | 2 | 1998 | 179 | 0.250 |
Why?
|
| Cerebrovascular Disorders | 11 | 1987 | 1474 | 0.250 |
Why?
|
| Ganglia, Spinal | 1 | 2007 | 526 | 0.240 |
Why?
|
| Kidney Diseases | 1 | 2015 | 2091 | 0.240 |
Why?
|
| Spinal Cord | 5 | 2003 | 1818 | 0.240 |
Why?
|
| Lyme Disease | 1 | 2010 | 631 | 0.240 |
Why?
|
| Electromyography | 10 | 2009 | 1394 | 0.230 |
Why?
|
| Vascular Endothelial Growth Factor A | 7 | 2009 | 3492 | 0.230 |
Why?
|
| Disabled Persons | 1 | 2014 | 1225 | 0.230 |
Why?
|
| Brain | 14 | 2021 | 27112 | 0.230 |
Why?
|
| Receptors, Dopamine D4 | 1 | 2024 | 170 | 0.230 |
Why?
|
| Interferon-beta | 1 | 2006 | 345 | 0.230 |
Why?
|
| Barbiturates | 1 | 2004 | 113 | 0.230 |
Why?
|
| Magnetic Resonance Imaging | 19 | 2013 | 36426 | 0.220 |
Why?
|
| Brain Death | 7 | 1987 | 357 | 0.220 |
Why?
|
| Half-Life | 1 | 2024 | 651 | 0.220 |
Why?
|
| Muscle Weakness | 2 | 2009 | 412 | 0.220 |
Why?
|
| Kleine-Levin Syndrome | 1 | 2002 | 4 | 0.220 |
Why?
|
| Male | 96 | 2016 | 360804 | 0.210 |
Why?
|
| Leg | 3 | 2006 | 1088 | 0.210 |
Why?
|
| Heroin | 1 | 2003 | 119 | 0.210 |
Why?
|
| Haloperidol | 1 | 2024 | 389 | 0.210 |
Why?
|
| Nootropic Agents | 1 | 2024 | 157 | 0.210 |
Why?
|
| Sarcoidosis | 2 | 2007 | 521 | 0.210 |
Why?
|
| Diagnostic Errors | 1 | 2010 | 1265 | 0.210 |
Why?
|
| Ischemia | 4 | 2001 | 1882 | 0.210 |
Why?
|
| Cerebral Hemorrhage | 11 | 1992 | 2656 | 0.200 |
Why?
|
| Spinal Cord Diseases | 3 | 2000 | 292 | 0.200 |
Why?
|
| Mycophenolic Acid | 1 | 2004 | 348 | 0.200 |
Why?
|
| Salivary Glands | 1 | 2003 | 229 | 0.200 |
Why?
|
| Female | 87 | 2016 | 392644 | 0.200 |
Why?
|
| Critical Care | 6 | 2003 | 2696 | 0.200 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2024 | 485 | 0.200 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2012 | 1413 | 0.200 |
Why?
|
| Military Personnel | 1 | 2011 | 1246 | 0.200 |
Why?
|
| Physicians | 3 | 2010 | 4591 | 0.190 |
Why?
|
| Acute Disease | 15 | 2017 | 7237 | 0.190 |
Why?
|
| Narcotics | 1 | 2003 | 336 | 0.190 |
Why?
|
| Middle Aged | 82 | 2012 | 220895 | 0.190 |
Why?
|
| Periodicals as Topic | 1 | 2012 | 1463 | 0.190 |
Why?
|
| Ganglia, Sensory | 1 | 2020 | 19 | 0.180 |
Why?
|
| Ganglia, Autonomic | 1 | 2021 | 43 | 0.180 |
Why?
|
| Anti-Bacterial Agents | 1 | 2019 | 7407 | 0.180 |
Why?
|
| Pain | 4 | 2013 | 5073 | 0.180 |
Why?
|
| Paraneoplastic Syndromes, Nervous System | 1 | 2020 | 24 | 0.180 |
Why?
|
| Neuralgia | 1 | 2007 | 615 | 0.180 |
Why?
|
| Poliomyelitis | 1 | 2001 | 92 | 0.180 |
Why?
|
| Antibodies, Viral | 1 | 2012 | 3156 | 0.180 |
Why?
|
| Immunoglobulin M | 4 | 2004 | 1527 | 0.180 |
Why?
|
| Hippocampus | 3 | 2023 | 3766 | 0.180 |
Why?
|
| Athletic Injuries | 2 | 2007 | 1216 | 0.180 |
Why?
|
| Stroke | 3 | 2017 | 9757 | 0.180 |
Why?
|
| Meningitis, Pneumococcal | 1 | 2000 | 43 | 0.180 |
Why?
|
| Peptides | 1 | 2012 | 4358 | 0.180 |
Why?
|
| Diagnosis, Differential | 10 | 2024 | 12974 | 0.170 |
Why?
|
| Health Care Reform | 1 | 2009 | 1247 | 0.170 |
Why?
|
| Acetaminophen | 1 | 2004 | 554 | 0.170 |
Why?
|
| Aged | 70 | 2011 | 169289 | 0.170 |
Why?
|
| Psychiatry | 1 | 2012 | 1693 | 0.170 |
Why?
|
| Quadriplegia | 2 | 2000 | 226 | 0.170 |
Why?
|
| Syphilis Serodiagnosis | 1 | 2019 | 37 | 0.170 |
Why?
|
| Cell Adhesion Molecules | 1 | 2006 | 1600 | 0.170 |
Why?
|
| Treponema pallidum | 1 | 2019 | 47 | 0.170 |
Why?
|
| Caffeine | 1 | 2004 | 700 | 0.170 |
Why?
|
| Reflex, Abnormal | 4 | 1994 | 83 | 0.170 |
Why?
|
| Walking | 2 | 2010 | 1198 | 0.170 |
Why?
|
| Patient Care | 1 | 2005 | 622 | 0.170 |
Why?
|
| Vasculitis | 1 | 2003 | 521 | 0.170 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2004 | 625 | 0.160 |
Why?
|
| Adult | 78 | 2010 | 221177 | 0.160 |
Why?
|
| Adrenal Cortex Hormones | 3 | 2004 | 1880 | 0.160 |
Why?
|
| Intensive Care Units | 4 | 2009 | 3745 | 0.160 |
Why?
|
| Coma | 7 | 1989 | 484 | 0.160 |
Why?
|
| Amyloid | 1 | 2024 | 841 | 0.160 |
Why?
|
| Neuromuscular Diseases | 3 | 2001 | 258 | 0.160 |
Why?
|
| Spinal Puncture | 2 | 2019 | 282 | 0.150 |
Why?
|
| Artificial Intelligence | 1 | 2013 | 2578 | 0.150 |
Why?
|
| Endothelial Growth Factors | 4 | 2001 | 673 | 0.150 |
Why?
|
| Electrodiagnosis | 5 | 2009 | 148 | 0.150 |
Why?
|
| Immunization, Passive | 2 | 2007 | 616 | 0.150 |
Why?
|
| Evoked Potentials, Somatosensory | 5 | 1990 | 246 | 0.150 |
Why?
|
| Cerebellum | 4 | 2000 | 1501 | 0.150 |
Why?
|
| Lymphokines | 4 | 2001 | 927 | 0.150 |
Why?
|
| Brain Mapping | 1 | 2013 | 6630 | 0.150 |
Why?
|
| Bone Neoplasms | 1 | 2010 | 2529 | 0.150 |
Why?
|
| Arrhythmia, Sinus | 2 | 1994 | 48 | 0.140 |
Why?
|
| Ataxia | 3 | 1995 | 306 | 0.140 |
Why?
|
| Brain Neoplasms | 4 | 2015 | 9031 | 0.140 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2007 | 1469 | 0.130 |
Why?
|
| Motor Neurons | 5 | 2007 | 870 | 0.130 |
Why?
|
| Interferon-alpha | 2 | 1998 | 921 | 0.130 |
Why?
|
| Neuromyelitis Optica | 1 | 2000 | 263 | 0.130 |
Why?
|
| Cerebral Infarction | 6 | 1994 | 983 | 0.130 |
Why?
|
| Auscultation | 4 | 1986 | 38 | 0.130 |
Why?
|
| Oculomotor Nerve | 2 | 1992 | 72 | 0.130 |
Why?
|
| Internship and Residency | 1 | 2016 | 5880 | 0.130 |
Why?
|
| Cerebrospinal Fluid | 5 | 2008 | 544 | 0.130 |
Why?
|
| Attitude of Health Personnel | 1 | 2009 | 3889 | 0.130 |
Why?
|
| Functional Laterality | 2 | 2001 | 2257 | 0.120 |
Why?
|
| Trauma Severity Indices | 1 | 2017 | 478 | 0.120 |
Why?
|
| Algorithms | 1 | 2016 | 14031 | 0.120 |
Why?
|
| Axons | 4 | 2000 | 1674 | 0.120 |
Why?
|
| Brain Ischemia | 5 | 2002 | 3049 | 0.120 |
Why?
|
| Foot Diseases | 1 | 1995 | 147 | 0.120 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2021 | 1432 | 0.120 |
Why?
|
| Touch Perception | 1 | 2015 | 107 | 0.120 |
Why?
|
| Practice Guidelines as Topic | 4 | 2021 | 7390 | 0.120 |
Why?
|
| Tomography, X-Ray Computed | 18 | 2021 | 20570 | 0.110 |
Why?
|
| Autonomic Nervous System Diseases | 3 | 1994 | 269 | 0.110 |
Why?
|
| Heparin | 1 | 2021 | 1634 | 0.110 |
Why?
|
| Electrophysiology | 9 | 2007 | 1262 | 0.110 |
Why?
|
| Osmotic Pressure | 1 | 2014 | 138 | 0.110 |
Why?
|
| Brain Diseases | 9 | 1999 | 1545 | 0.110 |
Why?
|
| Touch | 1 | 2015 | 313 | 0.110 |
Why?
|
| Neuritis | 1 | 1992 | 36 | 0.100 |
Why?
|
| Alzheimer Disease | 3 | 2024 | 8599 | 0.100 |
Why?
|
| Sural Nerve | 2 | 2007 | 105 | 0.100 |
Why?
|
| Pupil | 2 | 1991 | 146 | 0.100 |
Why?
|
| Writing | 1 | 2014 | 199 | 0.100 |
Why?
|
| Campylobacter Infections | 2 | 1991 | 31 | 0.100 |
Why?
|
| Brachial Plexus | 2 | 2010 | 167 | 0.100 |
Why?
|
| Celiac Disease | 1 | 2020 | 821 | 0.100 |
Why?
|
| Autoimmune Diseases | 3 | 2020 | 2244 | 0.100 |
Why?
|
| Cognition | 1 | 2010 | 6990 | 0.100 |
Why?
|
| Myelin-Associated Glycoprotein | 3 | 2007 | 107 | 0.100 |
Why?
|
| Antibodies, Monoclonal | 2 | 2007 | 9177 | 0.100 |
Why?
|
| Intracranial Arteriosclerosis | 4 | 1987 | 138 | 0.100 |
Why?
|
| Vasa Nervorum | 3 | 2007 | 5 | 0.100 |
Why?
|
| Consciousness | 2 | 1989 | 601 | 0.100 |
Why?
|
| Internet | 1 | 2004 | 3092 | 0.100 |
Why?
|
| Paraneoplastic Syndromes | 1 | 1993 | 155 | 0.100 |
Why?
|
| Foot | 2 | 1995 | 575 | 0.100 |
Why?
|
| Intracranial Embolism and Thrombosis | 3 | 1987 | 144 | 0.100 |
Why?
|
| Influenza Vaccines | 2 | 1998 | 768 | 0.100 |
Why?
|
| Postoperative Complications | 4 | 2012 | 15631 | 0.100 |
Why?
|
| Radiography | 2 | 2012 | 6965 | 0.090 |
Why?
|
| Primary Dysautonomias | 1 | 2011 | 28 | 0.090 |
Why?
|
| History, 20th Century | 3 | 2012 | 2767 | 0.090 |
Why?
|
| Carotid Artery, Internal, Dissection | 1 | 2011 | 42 | 0.090 |
Why?
|
| Early Diagnosis | 2 | 2024 | 1186 | 0.090 |
Why?
|
| Vagus Nerve | 1 | 1994 | 458 | 0.090 |
Why?
|
| History, 19th Century | 2 | 2012 | 720 | 0.090 |
Why?
|
| Respiratory Insufficiency | 2 | 1993 | 1230 | 0.090 |
Why?
|
| Pupil Disorders | 1 | 1990 | 32 | 0.090 |
Why?
|
| Bell Palsy | 1 | 2010 | 39 | 0.090 |
Why?
|
| Myelitis, Transverse | 2 | 1982 | 40 | 0.090 |
Why?
|
| Spine | 1 | 2017 | 1118 | 0.090 |
Why?
|
| Medicine | 1 | 2018 | 942 | 0.090 |
Why?
|
| Myelitis | 2 | 1982 | 49 | 0.090 |
Why?
|
| Age Factors | 2 | 2005 | 18395 | 0.090 |
Why?
|
| Facial Muscles | 2 | 1994 | 159 | 0.080 |
Why?
|
| Evoked Potentials | 3 | 1986 | 1038 | 0.080 |
Why?
|
| Cerebellar Neoplasms | 2 | 1993 | 586 | 0.080 |
Why?
|
| Central Nervous System Diseases | 2 | 1985 | 520 | 0.080 |
Why?
|
| Research Design | 1 | 2005 | 6180 | 0.080 |
Why?
|
| Action Potentials | 4 | 2009 | 1834 | 0.080 |
Why?
|
| Metrizamide | 2 | 1979 | 17 | 0.080 |
Why?
|
| New England | 1 | 2012 | 1054 | 0.080 |
Why?
|
| Cranial Nerve Diseases | 3 | 1994 | 113 | 0.080 |
Why?
|
| Prognosis | 8 | 2021 | 29625 | 0.080 |
Why?
|
| Neurons, Afferent | 3 | 2007 | 498 | 0.080 |
Why?
|
| Erectile Dysfunction | 1 | 1992 | 444 | 0.080 |
Why?
|
| Cerebrospinal Fluid Proteins | 2 | 2003 | 72 | 0.080 |
Why?
|
| Fluid Therapy | 1 | 2012 | 579 | 0.080 |
Why?
|
| Skin | 2 | 2015 | 4484 | 0.080 |
Why?
|
| Immunotherapy | 3 | 2020 | 4652 | 0.080 |
Why?
|
| Basilar Artery | 2 | 1988 | 205 | 0.080 |
Why?
|
| Clinical Medicine | 1 | 2009 | 145 | 0.080 |
Why?
|
| Hand | 2 | 1991 | 902 | 0.080 |
Why?
|
| Ascites | 1 | 2010 | 338 | 0.080 |
Why?
|
| Bacterial Infections | 1 | 1996 | 1390 | 0.070 |
Why?
|
| Ventilator Weaning | 1 | 2009 | 164 | 0.070 |
Why?
|
| Thorax | 1 | 2010 | 555 | 0.070 |
Why?
|
| Endovascular Procedures | 1 | 2021 | 2183 | 0.070 |
Why?
|
| Ophthalmoplegia | 1 | 1988 | 168 | 0.070 |
Why?
|
| Amnesia, Retrograde | 1 | 2007 | 19 | 0.070 |
Why?
|
| Dysarthria | 1 | 1987 | 58 | 0.070 |
Why?
|
| Nerve Fibers, Unmyelinated | 1 | 2007 | 98 | 0.070 |
Why?
|
| Respiratory Function Tests | 2 | 2010 | 1682 | 0.070 |
Why?
|
| Substance-Related Disorders | 1 | 2003 | 4420 | 0.070 |
Why?
|
| Pyramidal Cells | 1 | 2009 | 369 | 0.070 |
Why?
|
| Endarterectomy | 2 | 1986 | 196 | 0.070 |
Why?
|
| Facial Pain | 1 | 2007 | 120 | 0.070 |
Why?
|
| Chronic Disease | 8 | 2001 | 9318 | 0.070 |
Why?
|
| Hemiplegia | 2 | 1994 | 136 | 0.070 |
Why?
|
| Electroencephalography | 8 | 1987 | 6225 | 0.070 |
Why?
|
| Efficiency | 1 | 2009 | 476 | 0.070 |
Why?
|
| Speech Disorders | 1 | 1987 | 180 | 0.070 |
Why?
|
| History, 21st Century | 1 | 2012 | 1567 | 0.070 |
Why?
|
| Methylprednisolone | 1 | 2007 | 385 | 0.070 |
Why?
|
| Integrin alpha4 | 1 | 2006 | 87 | 0.070 |
Why?
|
| Motor Neuron Disease | 3 | 2007 | 97 | 0.060 |
Why?
|
| Immunoglobulin G | 1 | 1998 | 4544 | 0.060 |
Why?
|
| Anticoagulants | 2 | 2021 | 4812 | 0.060 |
Why?
|
| Aged, 80 and over | 16 | 2006 | 58976 | 0.060 |
Why?
|
| Synaptic Transmission | 2 | 2001 | 1173 | 0.060 |
Why?
|
| Subarachnoid Space | 2 | 1982 | 80 | 0.060 |
Why?
|
| Cerebrovascular Circulation | 3 | 1987 | 2727 | 0.060 |
Why?
|
| Acute-Phase Proteins | 1 | 2006 | 250 | 0.060 |
Why?
|
| Severity of Illness Index | 6 | 2009 | 15842 | 0.060 |
Why?
|
| Arterial Occlusive Diseases | 2 | 1988 | 748 | 0.060 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2007 | 240 | 0.060 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2008 | 790 | 0.060 |
Why?
|
| Jugular Veins | 1 | 1986 | 210 | 0.060 |
Why?
|
| Seizures | 2 | 2007 | 2957 | 0.060 |
Why?
|
| Abdomen | 1 | 2010 | 1128 | 0.060 |
Why?
|
| Malpractice | 1 | 2009 | 556 | 0.060 |
Why?
|
| Subarachnoid Hemorrhage | 4 | 1991 | 1033 | 0.060 |
Why?
|
| Double-Blind Method | 4 | 2009 | 12341 | 0.060 |
Why?
|
| Microscopy, Electron | 1 | 2007 | 2561 | 0.060 |
Why?
|
| Hip Fractures | 1 | 2012 | 988 | 0.060 |
Why?
|
| Jaw | 1 | 1984 | 93 | 0.060 |
Why?
|
| Reimbursement Mechanisms | 1 | 2009 | 667 | 0.060 |
Why?
|
| Treatment Outcome | 12 | 2009 | 64680 | 0.060 |
Why?
|
| Craniocerebral Trauma | 2 | 1985 | 490 | 0.050 |
Why?
|
| Eye Movements | 2 | 1990 | 511 | 0.050 |
Why?
|
| Cell Count | 1 | 2007 | 1835 | 0.050 |
Why?
|
| Optical Illusions | 1 | 1983 | 40 | 0.050 |
Why?
|
| Disability Evaluation | 2 | 2009 | 1835 | 0.050 |
Why?
|
| Blotting, Western | 1 | 2010 | 5035 | 0.050 |
Why?
|
| HLA-DR2 Antigen | 1 | 2002 | 44 | 0.050 |
Why?
|
| Drug Evaluation | 1 | 2004 | 641 | 0.050 |
Why?
|
| Carotid Arteries | 3 | 1986 | 941 | 0.050 |
Why?
|
| Status Epilepticus | 2 | 1986 | 460 | 0.050 |
Why?
|
| Illusions | 1 | 1983 | 61 | 0.050 |
Why?
|
| Fibrinogen | 1 | 2006 | 888 | 0.050 |
Why?
|
| Myelography | 3 | 1984 | 72 | 0.050 |
Why?
|
| Positron-Emission Tomography | 1 | 2019 | 6485 | 0.050 |
Why?
|
| Dementia | 3 | 2024 | 2686 | 0.050 |
Why?
|
| Pseudotumor Cerebri | 1 | 1984 | 108 | 0.050 |
Why?
|
| Autonomic Nervous System | 1 | 2007 | 703 | 0.050 |
Why?
|
| Potassium, Dietary | 1 | 2002 | 103 | 0.050 |
Why?
|
| Retrospective Studies | 11 | 2007 | 80636 | 0.050 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2004 | 278 | 0.050 |
Why?
|
| Hepatolenticular Degeneration | 2 | 1979 | 72 | 0.050 |
Why?
|
| Extremities | 1 | 2007 | 867 | 0.050 |
Why?
|
| Nerve Tissue Proteins | 2 | 2000 | 4414 | 0.050 |
Why?
|
| DNA, Viral | 1 | 2008 | 2202 | 0.050 |
Why?
|
| Orientation | 1 | 1983 | 321 | 0.050 |
Why?
|
| Thalidomide | 1 | 2007 | 885 | 0.050 |
Why?
|
| Nausea | 1 | 2004 | 679 | 0.050 |
Why?
|
| Diarrhea | 1 | 1988 | 1318 | 0.050 |
Why?
|
| Fatal Outcome | 2 | 2003 | 1834 | 0.050 |
Why?
|
| Nursing Process | 1 | 1981 | 17 | 0.050 |
Why?
|
| Blindness | 1 | 1985 | 584 | 0.050 |
Why?
|
| Autoantibodies | 2 | 2001 | 2116 | 0.050 |
Why?
|
| Spinal Nerve Roots | 2 | 1996 | 121 | 0.050 |
Why?
|
| Amoeba | 1 | 2000 | 20 | 0.050 |
Why?
|
| Amebiasis | 1 | 2000 | 33 | 0.040 |
Why?
|
| Nursing Assessment | 1 | 1981 | 106 | 0.040 |
Why?
|
| Heart | 1 | 1994 | 4404 | 0.040 |
Why?
|
| Kidney Failure, Chronic | 1 | 1993 | 2471 | 0.040 |
Why?
|
| Arm | 2 | 1999 | 589 | 0.040 |
Why?
|
| Administration, Inhalation | 1 | 2003 | 1157 | 0.040 |
Why?
|
| Hypoxia, Brain | 1 | 1981 | 138 | 0.040 |
Why?
|
| Intracranial Aneurysm | 3 | 1991 | 1285 | 0.040 |
Why?
|
| Parietal Lobe | 2 | 1982 | 852 | 0.040 |
Why?
|
| Anesthetics | 1 | 1986 | 523 | 0.040 |
Why?
|
| Apnea | 1 | 1981 | 195 | 0.040 |
Why?
|
| Sensory Thresholds | 1 | 2001 | 377 | 0.040 |
Why?
|
| Physical Examination | 1 | 2006 | 1255 | 0.040 |
Why?
|
| Median Nerve | 3 | 1986 | 132 | 0.040 |
Why?
|
| Medulla Oblongata | 2 | 1994 | 248 | 0.040 |
Why?
|
| Atrial Natriuretic Factor | 2 | 1991 | 350 | 0.040 |
Why?
|
| Meningoencephalitis | 1 | 2000 | 83 | 0.040 |
Why?
|
| Leukocyte Count | 1 | 2003 | 1596 | 0.040 |
Why?
|
| Causality | 1 | 2006 | 1242 | 0.040 |
Why?
|
| Ornithine Carbamoyltransferase Deficiency Disease | 1 | 1999 | 23 | 0.040 |
Why?
|
| Secondary Prevention | 1 | 2006 | 1475 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factors | 4 | 2001 | 748 | 0.040 |
Why?
|
| Biopsy | 3 | 2007 | 6766 | 0.040 |
Why?
|
| Paclitaxel | 1 | 2007 | 1732 | 0.040 |
Why?
|
| Drug Therapy, Combination | 2 | 2007 | 6310 | 0.040 |
Why?
|
| Intermittent Claudication | 1 | 2001 | 304 | 0.040 |
Why?
|
| Disorders of Excessive Somnolence | 1 | 2002 | 277 | 0.040 |
Why?
|
| Peripheral Nervous System | 1 | 2000 | 151 | 0.040 |
Why?
|
| Basal Ganglia | 1 | 1982 | 554 | 0.040 |
Why?
|
| Cisplatin | 1 | 2005 | 1651 | 0.040 |
Why?
|
| Drug Combinations | 2 | 2004 | 2048 | 0.040 |
Why?
|
| Frontal Lobe | 2 | 1982 | 1420 | 0.040 |
Why?
|
| Blood Pressure | 4 | 1992 | 8481 | 0.040 |
Why?
|
| Risk Factors | 4 | 2017 | 74206 | 0.040 |
Why?
|
| Lumbosacral Plexus | 2 | 1999 | 51 | 0.040 |
Why?
|
| Wounds, Nonpenetrating | 1 | 1985 | 807 | 0.040 |
Why?
|
| Carotid Artery Diseases | 3 | 1984 | 877 | 0.040 |
Why?
|
| Hematoma, Subdural | 3 | 1986 | 127 | 0.040 |
Why?
|
| Siblings | 1 | 2002 | 825 | 0.040 |
Why?
|
| Bone Marrow | 1 | 2008 | 2911 | 0.040 |
Why?
|
| Posture | 1 | 1982 | 957 | 0.040 |
Why?
|
| Safety | 1 | 2003 | 1150 | 0.040 |
Why?
|
| Sleep Stages | 3 | 1989 | 694 | 0.040 |
Why?
|
| Neuropeptides | 1 | 2004 | 944 | 0.040 |
Why?
|
| Potassium | 1 | 2002 | 1311 | 0.040 |
Why?
|
| Granuloma | 1 | 2000 | 328 | 0.040 |
Why?
|
| Cyclohexanecarboxylic Acids | 1 | 1999 | 140 | 0.040 |
Why?
|
| Glycoconjugates | 1 | 1998 | 88 | 0.040 |
Why?
|
| Blood Vessels | 1 | 2003 | 1113 | 0.040 |
Why?
|
| Statistics, Nonparametric | 1 | 2003 | 2850 | 0.040 |
Why?
|
| Movement Disorders | 2 | 1998 | 459 | 0.040 |
Why?
|
| Necrosis | 2 | 2000 | 1611 | 0.040 |
Why?
|
| Acetates | 1 | 1999 | 321 | 0.040 |
Why?
|
| Respiration, Artificial | 5 | 1993 | 2628 | 0.040 |
Why?
|
| Movement | 1 | 1984 | 1478 | 0.040 |
Why?
|
| Amines | 1 | 1999 | 281 | 0.040 |
Why?
|
| Recurrence | 5 | 2002 | 8465 | 0.040 |
Why?
|
| Evoked Potentials, Auditory | 3 | 1986 | 530 | 0.040 |
Why?
|
| Pyramidal Tracts | 1 | 1979 | 252 | 0.030 |
Why?
|
| Cerebral Cortex | 3 | 2009 | 5777 | 0.030 |
Why?
|
| Prospective Studies | 13 | 2007 | 54425 | 0.030 |
Why?
|
| Head | 1 | 1982 | 924 | 0.030 |
Why?
|
| Muscular Diseases | 2 | 1994 | 553 | 0.030 |
Why?
|
| United States | 3 | 2016 | 72334 | 0.030 |
Why?
|
| Neovascularization, Pathologic | 1 | 2007 | 2645 | 0.030 |
Why?
|
| Adolescent | 16 | 2002 | 88319 | 0.030 |
Why?
|
| Drainage | 1 | 1982 | 1157 | 0.030 |
Why?
|
| Ethchlorvynol | 1 | 1975 | 2 | 0.030 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 1981 | 710 | 0.030 |
Why?
|
| Hypotension | 2 | 2011 | 879 | 0.030 |
Why?
|
| Injections, Subcutaneous | 1 | 1997 | 681 | 0.030 |
Why?
|
| Reperfusion Injury | 1 | 2002 | 1023 | 0.030 |
Why?
|
| Guideline Adherence | 1 | 2005 | 2220 | 0.030 |
Why?
|
| Abducens Nerve | 1 | 1994 | 28 | 0.030 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2001 | 1119 | 0.030 |
Why?
|
| Cervical Plexus | 1 | 1994 | 16 | 0.030 |
Why?
|
| Proprioception | 1 | 1995 | 133 | 0.030 |
Why?
|
| Nystagmus, Pathologic | 1 | 1975 | 105 | 0.030 |
Why?
|
| Coronary Artery Bypass | 1 | 1983 | 2188 | 0.030 |
Why?
|
| Diabetic Nephropathies | 1 | 2001 | 973 | 0.030 |
Why?
|
| Follow-Up Studies | 6 | 2007 | 39106 | 0.030 |
Why?
|
| Foramen Magnum | 1 | 1993 | 41 | 0.030 |
Why?
|
| Cranial Nerves | 1 | 1994 | 98 | 0.030 |
Why?
|
| Muscle, Skeletal | 1 | 2009 | 4948 | 0.030 |
Why?
|
| Time Factors | 7 | 1993 | 39967 | 0.030 |
Why?
|
| Lymphocyte Activation | 1 | 2004 | 5486 | 0.030 |
Why?
|
| Viral Vaccines | 1 | 1998 | 596 | 0.030 |
Why?
|
| Staphylococcal Protein A | 1 | 1993 | 39 | 0.030 |
Why?
|
| Paraproteins | 1 | 1993 | 38 | 0.030 |
Why?
|
| Immunosorbent Techniques | 1 | 1993 | 175 | 0.030 |
Why?
|
| Nerve Degeneration | 1 | 1997 | 748 | 0.030 |
Why?
|
| Immunoglobulins | 2 | 1993 | 853 | 0.030 |
Why?
|
| Carotid Sinus | 1 | 1992 | 44 | 0.030 |
Why?
|
| Antigens | 1 | 1998 | 1443 | 0.030 |
Why?
|
| Orgasm | 1 | 1992 | 61 | 0.030 |
Why?
|
| Pentobarbital | 2 | 1983 | 153 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2004 | 8529 | 0.030 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 1999 | 1141 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2007 | 8181 | 0.030 |
Why?
|
| Campylobacter coli | 1 | 1991 | 1 | 0.020 |
Why?
|
| Campylobacter jejuni | 1 | 1991 | 24 | 0.020 |
Why?
|
| Down Syndrome | 1 | 1980 | 901 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 2006 | 3530 | 0.020 |
Why?
|
| Disease Progression | 1 | 2009 | 13506 | 0.020 |
Why?
|
| Methods | 2 | 1982 | 1067 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 1998 | 3416 | 0.020 |
Why?
|
| Purkinje Cells | 1 | 1993 | 226 | 0.020 |
Why?
|
| Evoked Potentials, Visual | 2 | 1986 | 417 | 0.020 |
Why?
|
| Cohort Studies | 4 | 2009 | 41487 | 0.020 |
Why?
|
| Muscles | 2 | 1993 | 1576 | 0.020 |
Why?
|
| Syndrome | 2 | 1988 | 3267 | 0.020 |
Why?
|
| Serologic Tests | 1 | 1993 | 381 | 0.020 |
Why?
|
| Clinical Trials as Topic | 3 | 2003 | 8002 | 0.020 |
Why?
|
| Reflex, Pupillary | 1 | 1990 | 62 | 0.020 |
Why?
|
| Wakefulness | 2 | 1989 | 1265 | 0.020 |
Why?
|
| Recombinant Proteins | 2 | 1998 | 6534 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2007 | 1246 | 0.020 |
Why?
|
| Biopsy, Needle | 1 | 1995 | 1626 | 0.020 |
Why?
|
| Rats | 5 | 2007 | 23742 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 1999 | 2571 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2000 | 2979 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 1998 | 6228 | 0.020 |
Why?
|
| Syncope | 1 | 1992 | 427 | 0.020 |
Why?
|
| Plasmids | 2 | 2007 | 2269 | 0.020 |
Why?
|
| Autoantigens | 1 | 1993 | 891 | 0.020 |
Why?
|
| Encephalitis | 3 | 1988 | 438 | 0.020 |
Why?
|
| Vertebral Artery | 2 | 1987 | 185 | 0.020 |
Why?
|
| Boston | 1 | 2001 | 9326 | 0.020 |
Why?
|
| Risk | 4 | 1984 | 9610 | 0.020 |
Why?
|
| Infusions, Intravenous | 1 | 1993 | 2219 | 0.020 |
Why?
|
| Fever | 1 | 1996 | 1618 | 0.020 |
Why?
|
| Critical Illness | 1 | 2001 | 2723 | 0.020 |
Why?
|
| Neurons | 1 | 2007 | 9463 | 0.020 |
Why?
|
| Mass Screening | 1 | 2024 | 5428 | 0.020 |
Why?
|
| Tandem Repeat Sequences | 1 | 2008 | 180 | 0.020 |
Why?
|
| Urinary Tract Infections | 1 | 1994 | 802 | 0.020 |
Why?
|
| Cerebral Arteries | 2 | 1987 | 490 | 0.020 |
Why?
|
| Pulmonary Embolism | 2 | 1994 | 2567 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2007 | 2455 | 0.020 |
Why?
|
| Ultrasonics | 1 | 1987 | 208 | 0.020 |
Why?
|
| Pregnancy | 1 | 2008 | 29874 | 0.020 |
Why?
|
| Sodium | 1 | 1991 | 1588 | 0.020 |
Why?
|
| Gastroenteritis | 1 | 1988 | 236 | 0.020 |
Why?
|
| Cerebral Aqueduct | 1 | 1986 | 40 | 0.020 |
Why?
|
| Renal Circulation | 1 | 2007 | 291 | 0.020 |
Why?
|
| Septum Pellucidum | 1 | 1986 | 54 | 0.020 |
Why?
|
| Hematoma, Epidural, Cranial | 1 | 1986 | 59 | 0.020 |
Why?
|
| Diagnostic Techniques, Neurological | 1 | 2006 | 62 | 0.020 |
Why?
|
| Multiple Sclerosis | 4 | 1982 | 3220 | 0.020 |
Why?
|
| Vestibulocochlear Nerve | 1 | 1986 | 115 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2003 | 10209 | 0.020 |
Why?
|
| Respiration | 1 | 1992 | 1657 | 0.020 |
Why?
|
| Reflex | 1 | 1987 | 376 | 0.020 |
Why?
|
| Cerebral Angiography | 3 | 1987 | 1281 | 0.020 |
Why?
|
| Antibodies, Bacterial | 1 | 1991 | 1469 | 0.020 |
Why?
|
| Injections, Intramuscular | 1 | 2007 | 554 | 0.020 |
Why?
|
| Intubation | 1 | 1985 | 139 | 0.020 |
Why?
|
| Blepharoptosis | 1 | 1986 | 144 | 0.020 |
Why?
|
| Antibodies | 1 | 1993 | 2418 | 0.020 |
Why?
|
| Pineal Gland | 1 | 1986 | 158 | 0.020 |
Why?
|
| Registries | 1 | 2001 | 8224 | 0.020 |
Why?
|
| Apoptosis | 3 | 2007 | 9486 | 0.020 |
Why?
|
| Tracheotomy | 1 | 1985 | 167 | 0.020 |
Why?
|
| Lectins | 1 | 2007 | 491 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2006 | 26125 | 0.010 |
Why?
|
| Phenylephrine | 1 | 1985 | 293 | 0.010 |
Why?
|
| Umbilical Veins | 1 | 2005 | 426 | 0.010 |
Why?
|
| Secretogranin II | 1 | 2004 | 9 | 0.010 |
Why?
|
| Reflex, Babinski | 1 | 1984 | 7 | 0.010 |
Why?
|
| Rabbits | 2 | 2001 | 4772 | 0.010 |
Why?
|
| Cells, Cultured | 3 | 2007 | 18965 | 0.010 |
Why?
|
| Endpoint Determination | 1 | 2007 | 590 | 0.010 |
Why?
|
| Cerebral Amyloid Angiopathy | 1 | 1991 | 895 | 0.010 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2007 | 694 | 0.010 |
Why?
|
| Heart Block | 1 | 1985 | 386 | 0.010 |
Why?
|
| Gene Rearrangement | 1 | 2008 | 1125 | 0.010 |
Why?
|
| Forecasting | 1 | 1992 | 2928 | 0.010 |
Why?
|
| Tinnitus | 1 | 1986 | 196 | 0.010 |
Why?
|
| Mesencephalon | 1 | 1985 | 332 | 0.010 |
Why?
|
| Compliance | 1 | 1982 | 100 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 1985 | 1379 | 0.010 |
Why?
|
| Incidence | 1 | 2001 | 21353 | 0.010 |
Why?
|
| Tachycardia | 1 | 1985 | 600 | 0.010 |
Why?
|
| Blood Substitutes | 1 | 1983 | 57 | 0.010 |
Why?
|
| Back Pain | 1 | 1986 | 545 | 0.010 |
Why?
|
| Drug Synergism | 1 | 2007 | 1755 | 0.010 |
Why?
|
| Ventricular Fibrillation | 1 | 1985 | 537 | 0.010 |
Why?
|
| Japan | 1 | 1987 | 1378 | 0.010 |
Why?
|
| Endothelium, Vascular | 2 | 2005 | 4431 | 0.010 |
Why?
|
| Vertebrobasilar Insufficiency | 1 | 1983 | 113 | 0.010 |
Why?
|
| Creatine Kinase | 1 | 1984 | 685 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2007 | 10766 | 0.010 |
Why?
|
| Form Perception | 1 | 1983 | 175 | 0.010 |
Why?
|
| Young Adult | 1 | 2009 | 59243 | 0.010 |
Why?
|
| Labyrinth Diseases | 1 | 1983 | 151 | 0.010 |
Why?
|
| Hearing Disorders | 1 | 1982 | 126 | 0.010 |
Why?
|
| Reference Values | 1 | 1989 | 4920 | 0.010 |
Why?
|
| Partial Pressure | 1 | 1981 | 245 | 0.010 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2011 | 2244 | 0.010 |
Why?
|
| Tibial Nerve | 1 | 2001 | 50 | 0.010 |
Why?
|
| Neoplasm Proteins | 1 | 1993 | 3617 | 0.010 |
Why?
|
| Streptozocin | 1 | 2001 | 194 | 0.010 |
Why?
|
| Vascular Resistance | 1 | 1984 | 930 | 0.010 |
Why?
|
| Laser-Doppler Flowmetry | 1 | 2001 | 239 | 0.010 |
Why?
|
| Carbon Monoxide Poisoning | 1 | 1981 | 65 | 0.010 |
Why?
|
| Heart Rate | 1 | 1992 | 4195 | 0.010 |
Why?
|
| Caudate Nucleus | 1 | 1982 | 389 | 0.010 |
Why?
|
| Random Allocation | 1 | 1985 | 2395 | 0.010 |
Why?
|
| Alcohol Amnestic Disorder | 1 | 1979 | 35 | 0.010 |
Why?
|
| Cerebral Ventricles | 1 | 1982 | 542 | 0.010 |
Why?
|
| Thrombosis | 1 | 1994 | 2942 | 0.010 |
Why?
|
| Optic Neuritis | 1 | 1982 | 174 | 0.010 |
Why?
|
| Neuropilin-1 | 1 | 2000 | 90 | 0.010 |
Why?
|
| Communication | 1 | 1994 | 3873 | 0.010 |
Why?
|
| Ornithine Carbamoyltransferase | 1 | 1999 | 26 | 0.010 |
Why?
|
| MAP Kinase Signaling System | 1 | 2007 | 1486 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2004 | 4511 | 0.010 |
Why?
|
| Accidents, Traffic | 1 | 1985 | 816 | 0.010 |
Why?
|
| Brain Diseases, Metabolic | 1 | 1979 | 44 | 0.010 |
Why?
|
| Pilot Projects | 2 | 2007 | 8631 | 0.010 |
Why?
|
| Sensation | 1 | 2001 | 337 | 0.010 |
Why?
|
| Diuretics | 1 | 2002 | 610 | 0.010 |
Why?
|
| Schwann Cells | 1 | 2000 | 197 | 0.010 |
Why?
|
| Tumor Burden | 1 | 2005 | 1893 | 0.010 |
Why?
|
| Receptors, Growth Factor | 1 | 2000 | 326 | 0.010 |
Why?
|
| Creutzfeldt-Jakob Syndrome | 1 | 1979 | 93 | 0.010 |
Why?
|
| Inflammation | 1 | 1999 | 10773 | 0.010 |
Why?
|
| Psychoses, Substance-Induced | 1 | 1979 | 99 | 0.010 |
Why?
|
| Animals | 7 | 2007 | 168459 | 0.010 |
Why?
|
| Hydrocephalus, Normal Pressure | 1 | 1979 | 100 | 0.010 |
Why?
|
| Language Disorders | 1 | 1979 | 140 | 0.010 |
Why?
|
| Occipital Lobe | 1 | 1980 | 374 | 0.010 |
Why?
|
| Optic Nerve Diseases | 1 | 1982 | 342 | 0.010 |
Why?
|
| Ammonia | 1 | 1999 | 237 | 0.010 |
Why?
|
| Neuroma, Acoustic | 1 | 1982 | 459 | 0.010 |
Why?
|
| Poisoning | 1 | 1979 | 252 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2001 | 1991 | 0.010 |
Why?
|
| Aphasia | 1 | 1979 | 192 | 0.010 |
Why?
|
| Hindlimb | 1 | 2000 | 513 | 0.010 |
Why?
|
| Head and Neck Neoplasms | 1 | 1992 | 2895 | 0.010 |
Why?
|
| Child | 5 | 1997 | 80153 | 0.010 |
Why?
|
| Stress, Physiological | 1 | 1985 | 1403 | 0.010 |
Why?
|
| Transgenes | 1 | 2001 | 1010 | 0.010 |
Why?
|
| Immunologic Techniques | 1 | 1997 | 212 | 0.010 |
Why?
|
| Immunologic Factors | 1 | 2007 | 1589 | 0.010 |
Why?
|
| Fluorocarbons | 1 | 1983 | 492 | 0.010 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2007 | 2865 | 0.010 |
Why?
|
| Carbon Dioxide | 1 | 1981 | 1147 | 0.010 |
Why?
|
| Auditory Perception | 1 | 1982 | 583 | 0.010 |
Why?
|
| Placebos | 1 | 2001 | 1667 | 0.010 |
Why?
|
| Cytomegalovirus | 1 | 2001 | 756 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 2002 | 2927 | 0.010 |
Why?
|
| Gene Dosage | 1 | 2001 | 1217 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2000 | 558 | 0.010 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 1 | 2000 | 664 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2001 | 1699 | 0.010 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 1992 | 4026 | 0.010 |
Why?
|
| Hemangiosarcoma | 1 | 1978 | 215 | 0.010 |
Why?
|
| Cell Division | 1 | 2004 | 4465 | 0.010 |
Why?
|
| France | 1 | 1997 | 497 | 0.010 |
Why?
|
| Cornea | 1 | 2004 | 1333 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 1993 | 9606 | 0.010 |
Why?
|
| Ultrasonography | 2 | 1986 | 5972 | 0.010 |
Why?
|
| Retinal Diseases | 1 | 1982 | 705 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2008 | 17635 | 0.010 |
Why?
|
| Image Enhancement | 1 | 1986 | 2885 | 0.010 |
Why?
|
| Reaction Time | 1 | 1982 | 2082 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2000 | 12148 | 0.010 |
Why?
|
| Radionuclide Imaging | 1 | 1979 | 1972 | 0.010 |
Why?
|
| Cyclophosphamide | 1 | 2001 | 2218 | 0.010 |
Why?
|
| Neutropenia | 1 | 2000 | 885 | 0.010 |
Why?
|
| Neurosurgery | 1 | 1982 | 679 | 0.010 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2005 | 2047 | 0.010 |
Why?
|
| Lumbosacral Region | 1 | 1996 | 293 | 0.010 |
Why?
|
| Activities of Daily Living | 1 | 1984 | 2421 | 0.010 |
Why?
|
| Intraoperative Complications | 1 | 1981 | 1165 | 0.010 |
Why?
|
| Endothelial Cells | 1 | 2007 | 3548 | 0.010 |
Why?
|
| Neovascularization, Physiologic | 1 | 2001 | 1349 | 0.010 |
Why?
|
| Hydrocephalus | 1 | 2000 | 764 | 0.010 |
Why?
|
| Outpatients | 1 | 2001 | 1597 | 0.010 |
Why?
|
| Visual Perception | 1 | 1982 | 1387 | 0.010 |
Why?
|
| Contrast Media | 1 | 1986 | 5311 | 0.010 |
Why?
|
| Hypertension | 2 | 2011 | 8540 | 0.010 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2008 | 3763 | 0.010 |
Why?
|
| Social Behavior | 1 | 1979 | 1135 | 0.010 |
Why?
|
| Heart Ventricles | 1 | 1985 | 3807 | 0.010 |
Why?
|
| Temporal Lobe | 1 | 1980 | 1695 | 0.010 |
Why?
|
| Huntington Disease | 1 | 1979 | 1144 | 0.010 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2000 | 1626 | 0.010 |
Why?
|
| Linear Models | 1 | 2002 | 5871 | 0.010 |
Why?
|
| Suicide, Attempted | 1 | 1981 | 1402 | 0.010 |
Why?
|
| Natriuresis | 1 | 1991 | 105 | 0.010 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 1979 | 1374 | 0.010 |
Why?
|
| Rupture, Spontaneous | 1 | 1991 | 362 | 0.010 |
Why?
|
| Blood Volume | 1 | 1991 | 547 | 0.010 |
Why?
|
| Cell Survival | 1 | 2000 | 5791 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2001 | 5789 | 0.010 |
Why?
|
| Hyponatremia | 1 | 1991 | 279 | 0.010 |
Why?
|
| Cytokines | 1 | 2004 | 7396 | 0.000 |
Why?
|
| Ischemic Attack, Transient | 2 | 1984 | 882 | 0.000 |
Why?
|
| Gene Expression | 1 | 2001 | 7581 | 0.000 |
Why?
|
| Cell Movement | 1 | 2000 | 5203 | 0.000 |
Why?
|
| Delirium | 1 | 1979 | 1668 | 0.000 |
Why?
|
| Proportional Hazards Models | 1 | 2002 | 12463 | 0.000 |
Why?
|
| Transducers | 1 | 1988 | 244 | 0.000 |
Why?
|
| Cerebral Arterial Diseases | 1 | 1986 | 82 | 0.000 |
Why?
|
| Mental Disorders | 2 | 1991 | 6845 | 0.000 |
Why?
|
| Leukemia, Hairy Cell | 1 | 1986 | 82 | 0.000 |
Why?
|
| Cognition Disorders | 1 | 1979 | 3979 | 0.000 |
Why?
|
| T-Lymphocytes | 1 | 1982 | 10194 | 0.000 |
Why?
|
| Herpes Simplex | 1 | 1988 | 478 | 0.000 |
Why?
|
| Dipyridamole | 1 | 1984 | 140 | 0.000 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 1991 | 3810 | 0.000 |
Why?
|
| Plethysmography | 1 | 1984 | 175 | 0.000 |
Why?
|
| Bacterial Vaccines | 1 | 1986 | 401 | 0.000 |
Why?
|
| Reye Syndrome | 1 | 1983 | 28 | 0.000 |
Why?
|
| Diabetes Mellitus | 1 | 2001 | 5840 | 0.000 |
Why?
|
| Influenza A virus | 1 | 1986 | 458 | 0.000 |
Why?
|
| Pneumococcal Vaccines | 1 | 1986 | 397 | 0.000 |
Why?
|
| Carotid Artery, Internal | 1 | 1984 | 445 | 0.000 |
Why?
|
| Tomography, Emission-Computed | 1 | 1984 | 1122 | 0.000 |
Why?
|
| Signal Transduction | 1 | 2004 | 23445 | 0.000 |
Why?
|
| Disease Models, Animal | 1 | 2000 | 18252 | 0.000 |
Why?
|
| Prevalence | 1 | 1997 | 15732 | 0.000 |
Why?
|
| Remission, Spontaneous | 1 | 1979 | 384 | 0.000 |
Why?
|
| Mice | 1 | 2004 | 81525 | 0.000 |
Why?
|
| Drug Resistance | 1 | 1983 | 1596 | 0.000 |
Why?
|
| Neoplasms | 1 | 2005 | 22170 | 0.000 |
Why?
|
| Child, Preschool | 1 | 1978 | 42230 | 0.000 |
Why?
|
| Blood Platelets | 1 | 1984 | 2479 | 0.000 |
Why?
|
| Aspirin | 1 | 1984 | 3133 | 0.000 |
Why?
|
| Macrophages | 1 | 1986 | 5769 | 0.000 |
Why?
|
| Infant | 1 | 1983 | 36192 | 0.000 |
Why?
|